| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Polynuclear iron(III)-oxyhydroxide (pn-FeOOH) |
| Brand | Velphoro® |
| Indication | Is indicated for the control of serum phosphorus levels in adult chronic kidney disease (CKD) patients on haemodialysis (HD) or peritoneal dialysis (PD). Rapid Review |
| Assessment Process | |
| Rapid review commissioned | 12/09/2014 |
| Rapid review completed | 08/10/2014 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended |